OncoLab Diagnostics GmbH develops, manufactures, and distributes products for in vitro diagnostic applications and research.
R&D:Oncology (circulating rare cells, like circulating tumor cells; tumor suppressor protein aggregation). Virology (SARS-CoV-2 and other respiratory infectious diseases).
Production:Production of laboratory tests for research in IVD use will commence in Q1/2021.
Sales/Distribution:First sale expected in Q2/2021. Global sales through a network of distributors.